Home › Free Stock Grades › AORT
Artivion, Inc. (AORT) Stock Grade
AORT · Healthcare
A+
Market Cap
$2.1B
P/E Ratio
211.7
Revenue Growth (YoY)
+13.6%
Net Margin
2.2%
Return on Equity
2.2%
Dividend Yield
None
About Artivion, Inc.'s fundamentals
Artivion is a $2.1 billion medical device company with strong revenue growth of 13.6% year-over-year, indicating expanding sales in its market. However, profitability metrics are thin, with a net margin of just 2.2% and return on equity of 2.2%, suggesting the company converts only a small portion of revenues into profits. The stock trades at a notably elevated P/E ratio of 211.7, reflecting either high growth expectations or limited current earnings, and the company does not pay a dividend.